EGR1 is known to function synergistically with NF-κB in upregulating IL-8 production in prostate cancer cells (Ma et al., 2009), and that its expression can be regulated by EGFR-integrin crosstalk (Cabodi et al., 2009). Here, CXCL8 is linked to prostate carcinoma.